BridgeMD
Compares treatment options for Pseudotumor Cerebri
Official title Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.
ClinicalTrials.gov ID: NCT05050864
What this study is testing
- What it's testing
- Idiopathic intracranial hypertension (HTICi) is a pathology, affecting young adults with a predominance of women, due to an increase in intracranial pressure, which may be associated with stenosis of the cerebral venous sinuses and whose origin remains unknown. This hypertension can lead to papillary edema (OP) which can lead to a narrowing of the visual field and progress to blindness.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient aged 18 or over
- HTICi proven greater than 25cm of water
- Presence of papillary edema (grade\> 0 on the Frisen scale)
- Stenosis of at least one transverse sinus on MRI
- Failure of medical treatment and surgical / treatment indication defined by the medical team taking care of the patient
You likely can't join if
- Fulminant HTICi
- Contraindication to antiplatelet aggregation
- Contraindication to one or the other of the interventions under study
- Pregnant or breastfeeding woman
See the full eligibility criteria
- Patient aged 18 or over
- HTICi proven greater than 25cm of water
- Presence of papillary edema (grade\> 0 on the Frisen scale)
- Stenosis of at least one transverse sinus on MRI
- Failure of medical treatment and surgical / treatment indication defined by the medical team taking care of the patient
- Consent to participate in the study
- Fulminant HTICi
- Contraindication to antiplatelet aggregation
- Contraindication to one or the other of the interventions under study
- Pregnant or breastfeeding woman
The study team makes the final eligibility decision.
Where it's taking place
- Paris, Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.